Loading clinical trials...
Loading clinical trials...
In this study, it is aimed to compare the lesion location, lesion size, local and distant metastases detection rates of Ga68 PSMA PET and Multiparametric Prostate MR imaging tests used in staging in patients diagnosed with prostate cancer. The pathologies of the patients who were decided to undergo radical prostatectomy as a treatment will also be compared with the staging tests.
Age
All ages
Sex
MALE
Healthy Volunteers
No
Gulhane Research and Training Hospital
Ankara, Etlik, Turkey (Türkiye)
Start Date
January 1, 2020
Primary Completion Date
January 5, 2023
Completion Date
March 5, 2023
Last Updated
June 28, 2022
47
ESTIMATED participants
Multiparametric Prostate MRI
DIAGNOSTIC_TEST
Lead Sponsor
Gulhane Training and Research Hospital
NCT04550494
NCT06842498
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05691465